Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Role of the Circadian System in Binge Eating Disorder

NCT: NCT04724668 · COMPLETED

NCT IDNCT04724668
StatusCOMPLETED
Start Date2021-01-15
Completion2025-05-30
SponsorUniversity of Cincinnati (OTHER)
First posted
Last updated

Brief Summary

Binge eating disorder (BED) shows prominent circadian features that suggest a delay in circadian phase, and preliminary evidence shows binge eating may be responsive to chronobiological interventions, implicating a circadian system dysfunction in its pathophysiology. What remains lacking, however, is comprehensive knowledge of the characteristics of circadian system dysfunction in BED, and whether this dysfunction represents a therapeutic target in BED. There is therefore a critical need to characterize circadian system dysfunction in BED, and evaluate it as a potential therapeutic target. Without such information, the understanding on the role of the circadian system in BED and its potential as a new therapeutic target will remain limited.

Frequently Asked Questions

What is The Role of the Circadian System in Binge Eating Disorder?

The Role of the Circadian System in Binge Eating Disorder is a clinical trial registered under NCT04724668. Current status: COMPLETED.

What is the status of NCT04724668?

The current status of NCT04724668 (The Role of the Circadian System in Binge Eating Disorder) is: COMPLETED.

When did The Role of the Circadian System in Binge Eating Disorder start?

The Role of the Circadian System in Binge Eating Disorder started on 2021-01-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.